Phase
Condition
Sickle Cell Disease
Blood Cancer
Hematologic Neoplasms
Treatment
Let's Get REAL
Clinical Study ID
Ages > 8 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria Youth:
Children or adolescents 8-17 years of age referred for SCTCT.
Diagnosis of malignant or nonmalignant disorder.
Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
Planning to meet with a provider to discuss SCTCT.
Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed assent document.
Must speak English and be cognitively able to participate.
Inclusion Criteria Parents:
Parent or guardian of a child 8-17 years of age with any diagnosis referred for any type of SCTCT. Diagnoses may include malignant and nonmalignant disorders. Autologous and allogeneic stem cell and cellular therapies are eligible. Parent or guardian is defined as an adult who usually cares for the youth and has authority to make medical decisions for them.
Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed consent document.
Must speak English and be cognitively able to participate.
Exclusion Criteria Youth:
Active medical problems severe enough to preclude study participation at the time of recruitment.
Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
Lacks cognitive capacity to complete study activities, as determined by consenting professional.
Exclusion Criteria Parents:
- Their youth referred for SCTCT does not assent to participate.
Study Design
Connect with a study center
Washington University School of Medicine
Saint Louis, Missouri 63110
United StatesSite Not Available
Washington University School of Medicine
St Louis 4407066, Missouri 4398678 63110
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.